
The episode discusses next-generation treatment pathways in prostate cancer with practical guidance for individualizing patient care.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/FMP865. CME/MOC/AAPA/IPCE credit will be available until June 16, 2027. Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc. and Blue Earth Diagnostics. Disclosure information is available at the beginning of the video presentation.
Guest: Fred Saad
Bayer HealthCare Pharmaceuticals Inc., Blue Earth Diagnostics
Organizations: PVI, PeerView Institute for Medical Education, ZERO Prostate Cancer, Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Nurses Credentialing Center (ANCC)
Explore listener stats, chart rankings, contacts and more on the PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast podcast page.